Akebia Announces $50M Public Offering
Deal News | Mar 20, 2025 | Wilmer Cutler Pickering Hale and Dorr LLP

Akebia Therapeutics, Inc., a biopharmaceutical company dedicated to kidney disease treatment, has announced the pricing of its public offering of 25 million common shares at $2.00 per share, resulting in expected gross proceeds of $50 million prior to underwriting and other expenses. The underwriters retain a 30-day option to purchase an additional 3.75 million shares. The offering is advised by WilmerHale, with a legal team comprising Stuart Falber, Caroline Dotolo, Katharine Patterson, Rachael Joseph, and Whitley Horning.
Sectors
- Biopharmaceuticals
- Legal Advisory
Geography
- United States – The primary geography involved is the United States as Akebia Therapeutics is based in the US and the public offering is being conducted there.
Industry
- Biopharmaceuticals – Akebia Therapeutics is part of the biopharmaceutical industry, focusing on therapies for kidney disease.
- Legal Advisory – WilmerHale is involved in the legal advisory industry, providing legal counsel for Akebia's public offering.
Financials
- 50,000,000 – Gross proceeds expected from Akebia's public offering.
- 2.00 – Public offering price per share for Akebia's common stock.
- 25,000,000 – Number of shares offered in the public offering.
- 3,750,000 – Additional shares available for underwriters to purchase.
Participants
Name | Role | Type | Description |
---|---|---|---|
Akebia Therapeutics, Inc. | Target Company | Company | A biopharmaceutical company working on treatments for kidney disease. |
Wilmer Cutler Pickering Hale and Dorr LLP | Legal Advisor | Company | A law firm advising Akebia on their public offering. |
Stuart Falber | Legal Advisor | Person | Part of the WilmerHale team advising Akebia Therapeutics. |
Caroline Dotolo | Legal Advisor | Person | Part of the WilmerHale team advising Akebia Therapeutics. |
Katharine Patterson | Legal Advisor | Person | Part of the WilmerHale team advising Akebia Therapeutics. |
Rachael Joseph | Legal Advisor | Person | Part of the WilmerHale team advising Akebia Therapeutics. |
Whitley Horning | Legal Advisor | Person | Part of the WilmerHale team advising Akebia Therapeutics. |